Pancreatic adenocarcinoma is one of the most lethal cancer types, currently lacking efficient treatment. The heterogeneous nature of these tumours are poorly represented by the classical pancreatic cell lines, which have been through strong clonal selection in vitro, and are often derived from metastases. Here, we describe the establishment of novel pancreatic adenocarcinoma models, xenografts and corresponding in vitro cell lines, from primary pancreatic tumours. The morphology, differentiation grade and gene expression pattern of the xenografts resemble the original tumours well. The cell lines were analysed for colony forming capacity, tumourigenicity and expression of known cancer cell surface markers and cancer stem-like characteristic...
Pancreatic cancer (PC) remains one of the most lethal human malignancies with poor prognosis. Despit...
Pancreatic ductal adenocarcinoma (PDA) is one of the most difficult human malignancies to treat. The...
Direct implantation of viable surgical specimens provides a representative preclinical platform in p...
Pancreatic adenocarcinoma is one of the most lethal cancer types, currently lacking efficient treatm...
<div><p>Pancreatic adenocarcinoma is one of the most lethal cancer types, currently lacking efficien...
In highly aggressive malignancies like pancreatic cancer (PC), patient-derived tumor models can serv...
Pancreatic cancer is the one of the deadliest of all malignancies. The five year survival rate for p...
Pancreatic cancer is the one of the deadliest of all malignancies. The five year survival rate for p...
Pancreatic cancer is the one of the deadliest of all malignancies. The five year survival rate for p...
Pancreatic ductal adenocarcinoma (PDAC) is the most representative form of pancreatic cancers. PDAC ...
Aims: New concepts of tumorigenesis favor an unregulated process recapitulating different stages of ...
BACKGROUND:Relevant preclinical models that recapitulate the key features of human pancreatic ductal...
Abstract Background Pancreatic ductal adenocarcinomas are among the most malignant neoplasms and hav...
Pancreatic Ductal Adenocarcinoma (PDAC) is the fourth most common cause of cancer-related death and ...
To assess the viability of orthotopic and heterotopic patient-derived pancreatic cancer xenografts i...
Pancreatic cancer (PC) remains one of the most lethal human malignancies with poor prognosis. Despit...
Pancreatic ductal adenocarcinoma (PDA) is one of the most difficult human malignancies to treat. The...
Direct implantation of viable surgical specimens provides a representative preclinical platform in p...
Pancreatic adenocarcinoma is one of the most lethal cancer types, currently lacking efficient treatm...
<div><p>Pancreatic adenocarcinoma is one of the most lethal cancer types, currently lacking efficien...
In highly aggressive malignancies like pancreatic cancer (PC), patient-derived tumor models can serv...
Pancreatic cancer is the one of the deadliest of all malignancies. The five year survival rate for p...
Pancreatic cancer is the one of the deadliest of all malignancies. The five year survival rate for p...
Pancreatic cancer is the one of the deadliest of all malignancies. The five year survival rate for p...
Pancreatic ductal adenocarcinoma (PDAC) is the most representative form of pancreatic cancers. PDAC ...
Aims: New concepts of tumorigenesis favor an unregulated process recapitulating different stages of ...
BACKGROUND:Relevant preclinical models that recapitulate the key features of human pancreatic ductal...
Abstract Background Pancreatic ductal adenocarcinomas are among the most malignant neoplasms and hav...
Pancreatic Ductal Adenocarcinoma (PDAC) is the fourth most common cause of cancer-related death and ...
To assess the viability of orthotopic and heterotopic patient-derived pancreatic cancer xenografts i...
Pancreatic cancer (PC) remains one of the most lethal human malignancies with poor prognosis. Despit...
Pancreatic ductal adenocarcinoma (PDA) is one of the most difficult human malignancies to treat. The...
Direct implantation of viable surgical specimens provides a representative preclinical platform in p...